title: Radiolabeled somatostaitin analogs in the treatment of neuroendocrine tumors: experience of the National Cancer Institute of Milano using high dose of 111In-pentetreotide in metastatic neuroendocrine gastroenteropancreatic tumors.
authors.affiliation: Nuclear Medicine Division, Italian Trials of Medical Oncology, National Cancer Institute, Milan, Italy. bombardieri@istitutotumori.mi.it
authors.forename: E
authors.initials: E
authors.lastname: Bombardieri
authors.forename: E
authors.initials: E
authors.lastname: Seregni
authors.forename: G
authors.initials: G
authors.lastname: Savelli
authors.forename: C
authors.initials: C
authors.lastname: Villano
authors.forename: M R
authors.initials: MR
authors.lastname: Castellani
authors.forename: F
authors.initials: F
authors.lastname: Cirillo
authors.forename: F
authors.initials: F
authors.lastname: Pallotti
authors.forename: S
authors.initials: S
authors.lastname: Fracassi
authors.forename: C
authors.initials: C
authors.lastname: Chiesa
authors.forename: A
authors.initials: A
authors.lastname: Chiti
authors.forename: E
authors.initials: E
authors.lastname: Bajetta
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D006801:Humans; D007205:Indium Radioisotopes / Q000627:therapeutic use*; D007558:Italy; D008297:Male; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging / Q000188:drug therapy*; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011829:Radiation Dosage; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D007205:Indium Radioisotopes; D019275:Radiopharmaceuticals; D013004:Somatostatin; C081788:pentetreotide